Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC
A manuscript that wil certainly be discussed in lung MDT! The thought of a RCT in these earlier stages may be already in the mind of the sponsors… The authors do not report synergic side effects so far.
0
0 comments